Enanta Pharmaceuticals (ENTA) Net Margin Growth (5y) (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Enanta Pharmaceuticals | 367.22 Mn | 203.44 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 10,384.00 |
| Dec 31, 2025 | -3,790.00 |
| Sep 30, 2025 | 53.00 |
| Jun 30, 2025 | -2,320.00 |
| Mar 31, 2025 | -12,997.00 |
| Dec 31, 2024 | -15,701.00 |
| Sep 30, 2024 | -21,391.00 |
| Jun 30, 2024 | -14,194.00 |
| Mar 31, 2024 | -19,316.00 |
| Dec 31, 2023 | -22,278.00 |
| Sep 30, 2023 | -18,926.00 |
| Jun 30, 2023 | -24,221.00 |
| Mar 31, 2023 | -24,012.00 |
| Dec 31, 2022 | -15,358.00 |
| Sep 30, 2022 | -22,636.00 |
| Jun 30, 2022 | 5,870.00 |
| Mar 31, 2022 | -3,971.00 |
| Dec 31, 2021 | -3,151.00 |
| Sep 30, 2021 | -32,052.00 |
| Jun 30, 2021 | -10,961.00 |
| Mar 31, 2021 | -19,136.00 |
| Dec 31, 2020 | -12,048.00 |
| Sep 30, 2020 | -14,188.00 |
| Jun 30, 2020 | -8,994.00 |
| Mar 31, 2020 | -14,165.00 |
| Dec 31, 2019 | -10,219.00 |
| Sep 30, 2019 | 20,911.00 |
| Jun 30, 2019 | -10,317.00 |
| Mar 31, 2019 | 25,134.00 |
| Dec 31, 2018 | 63,856.00 |
| Sep 30, 2018 | 37,016.00 |
| Jun 30, 2018 | 28,637.00 |
| Mar 31, 2018 | 44,598.00 |
| Dec 31, 2017 | 2,398.00 |
| Sep 30, 2017 | 12,041.00 |
| Jun 30, 2017 | -3,139.00 |
| Mar 31, 2017 | -14,696.00 |